Not everyone will be able to get corona vaccine by 2024, largest company bid

Not everyone will be able to get corona vaccine by 2024, largest company bid

Not everyone will be able to get corona vaccine by 2024, largest company bid. CEO of Serum Institute of India, the world’s largest vaccine-producing company, Adar Poonawalla has said that even by 2024, such a vaccine will not be ready so that all people in the world get the food. He has also expressed concern about reaching the vaccine to all the people of India. According to the report published in the Financial Times, Adar Poonawalla says that the pharmaceutical companies have not been able to increase their production capacity so that the vaccine can be given to the whole world in a short time.

Not everyone will be able to get corona vaccine by 2024, largest company bid

According to ft.com report, Adar Poonawala said- ‘It will take 4 to 5 years to give the vaccine to all the people on earth.’ He said that if a person needs two doses of corona vaccine then 15 billion doses will be needed for the whole world.

Adar Poonawala also raised concerns about the vaccine being delivered to 1.4 billion people in India because there is no cold chain system for transporting the vaccine. Please tell that after the vaccine is ready, it is to be kept in the freezer and cold chain system is needed to move it from one place to another.

Adar Poonawala said- ‘I am still unable to see any concrete plan that will allow more than 40 crores (of India) to get the vaccine. You do not want any such situation that you have the capacity to produce the vaccine for your country, but you cannot consume it.

The Pune-based company Serum Institute of India has tied up with five international companies for the production of the corona vaccine. These include companies such as AstraZeneca and Novavax. The Serum Institute aims to produce one billion vaccine doses, of which half will be given to India.

Adar Poonawala also told the Financial Times that he was in talks to raise $ 600 million from Saudi Arabia’s Public Investment Fund (PIF), Abu Dhabi Investment Holding Company ADQ and US private equity firm TPG to increase vaccine production capacity Huh. However, PIF and TPG refused to respond to this.